Literature DB >> 17192921

Androgens and androgen receptors: a clinically neglected sector in breast cancer biology.

Roger E Moe, Benjamin O Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17192921     DOI： 10.1002/jso.20722

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  8 in total

1.  Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers.

Authors:  Donata Micello; Alessandro Marando; Nora Sahnane; Cristina Riva; Carlo Capella; Fausto Sessa
Journal:  Virchows Arch       Date:  2010-08-31       Impact factor: 4.064

2.  Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.

Authors:  Ji-Ping Qi; You-Lin Yang; Hong Zhu; Jianmin Wang; Ying Jia; Na Liu; Yue-Jia Song; Li-Kun Zan; Xu Zhang; Min Zhou; Yun-He Gu; Tao Liu; David G Hicks; Ping Tang
Journal:  Breast Cancer (Auckl)       Date:  2011-12-06

3.  Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

Authors:  Pierluigi Gasparini; Matteo Fassan; Luciano Cascione; Gulnur Guler; Serdar Balci; Cigdem Irkkan; Carolyn Paisie; Francesca Lovat; Carl Morrison; Jianying Zhang; Aldo Scarpa; Carlo M Croce; Charles L Shapiro; Kay Huebner
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

4.  Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.

Authors:  Dawn R Cochrane; Sebastián Bernales; Britta M Jacobsen; Diana M Cittelly; Erin N Howe; Nicholas C D'Amato; Nicole S Spoelstra; Susan M Edgerton; Annie Jean; Javier Guerrero; Francisco Gómez; Satyanarayana Medicherla; Iván E Alfaro; Emma McCullagh; Paul Jedlicka; Kathleen C Torkko; Ann D Thor; Anthony D Elias; Andrew A Protter; Jennifer K Richer
Journal:  Breast Cancer Res       Date:  2014-01-22       Impact factor: 6.466

5.  Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide.

Authors:  Xiaohong Xia; Chuyi Huang; Yuning Liao; Yuan Liu; Jinchan He; Zhiqiang Guo; Lili Jiang; Xuejun Wang; Jinbao Liu; Hongbiao Huang
Journal:  J Exp Clin Cancer Res       Date:  2019-05-24

6.  Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family.

Authors:  Sandeep Sanga; Bradley M Broom; Vittorio Cristini; Mary E Edgerton
Journal:  BMC Med Genomics       Date:  2009-09-11       Impact factor: 3.063

7.  Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.

Authors:  Pietro Rizza; Ines Barone; Domenico Zito; Francesca Giordano; Marilena Lanzino; Francesca De Amicis; Loredana Mauro; Diego Sisci; Stefania Catalano; Karin Dahlman Wright; Jan-Ake Gustafsson; Sebastiano Andò
Journal:  Breast Cancer Res       Date:  2014-02-19       Impact factor: 6.466

8.  Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.

Authors:  Anil Agrawal; Piotr Ziolkowski; Zygmunt Grzebieniak; Michal Jelen; Piotr Bobinski; Siddarth Agrawal
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.